Men1611, A Pi3K Inhibitor, Combined With Trastuzumab +- Fulvestrant For Her2+/Pik3Ca Mutant Advanced Or Metastatic Breast Cancer: Updated Safety And Efficacy Results From The Ongoing Phase 1B Study (B-Precise-01)
MEN-1611;Trastuzumab;Fulvestrant
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Men1611, A Pi3K Inhibitor, Combined With Trastuzumab +- Fulvestrant For Her2+/Pik3Ca Mutant Advanced Or Metastatic Breast Cancer: Updated Safety And Efficacy Results From The Ongoing Phase 1B Study (B-Precise-01) ### Output: MEN-1611;Trastuzumab;Fulvestrant